Re N Agade Therapeutics Appoints Laurie Stelzer As Chief Financial Officer
09/12/23, 5:27 PM
Location
cambridge
Position
chief financial officer
CAMBRIDGE, Mass.–– ReNAgade Therapeutics , a company unlocking the limitless potential for RNA medicines , today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgade’s leadership team.
Company Info
Location
cambridge, massachusetts, united states
Additional Info
ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines.
To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.